Form D · Biotechnology
Harpoon Medical, Inc.
Baltimore, MD · CIK 0001617836
Offering snapshot reported Jan 7, 2016 · SEC filing
- Reported sold
- $3.9M Offering amount: $4M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 8, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 7, 2016 | Initial | $3,901,122 | No comparison | 19 | SEC filing |
| Aug 27, 2014 | Initial | $3,908,147 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-254723
Issuance and sale of shares of Series B Preferred Stock and the underlying shares of Common Stock issuable upon conversion thereof.
Source: Form D, filed Jan 7, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Boyd | Executive |
| Mark Collins | Executive |
| James Cox | Director |
| James Gammie | Director |
| William Niland | Director, Executive |
| Kyparissia Sirinakis | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
323 West Camden Street Suite 675
Baltimore, MD, 21201
Baltimore, MD, 21201